Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658146 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 95
- Enrollment target
NCT05658146: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT05658146 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 95 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05658146, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects on the single-dose drug levels of mavacamten in healthy participants.
Interventions
- DRUG Mavacamten Capsule 1
- DRUG Mavacamten Capsule 2
- DRUG Mavacamten Capsule 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2023-07-05 |
| Phase | Phase 1 |
What the finished NCT05658146 record still lists
NCT05658146 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% higher).
The record links to 0 conditions, and to 3 interventions - of which Mavacamten Capsule 1 is the first listed.
NCT05658146 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05658146 about?
NCT05658146 is a clinical study titled "A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants". The purpose of this study is to assess the effects on the single-dose drug levels of mavacamten in healthy participants.
What is the current status of trial NCT05658146?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 95 participants. The study started on 2023-01-06. Estimated completion is 2023-07-05.
What interventions are being tested in trial NCT05658146?
The interventions under investigation include: Mavacamten Capsule 1 (DRUG), Mavacamten Capsule 2 (DRUG), Mavacamten Capsule 3 (DRUG).
Who is sponsoring clinical trial NCT05658146?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05658146's enrollment target sits among peer trials
95 610th of 2000 higher than 1,386 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI